3AvgerinosA,ArmonisA,Raptis S. Somatostatin and octreotide in the management of acute varieeal hemorrhage[J]. Hepatogastroenterology,1995,42(2):145-150.
4Yeh JL,Peng YC,Tung CF. Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma [J]. Dig Dis Sci,2002,47(4) :723-729.
5Bhasin DK, Malhi NJ. Variceal bleeding and portal hypertention:much to learn,much to explore[J]. Endoscopy, 2002, 34 (2):119-128.
6Cheng CY, Chen GH, Chang CS. Sclerotherapy for esophageal variceal bleeding in advanced hepatocellular cardnoma: an &year experience in Taiwan[J]. J Gastroenterol,1994,29(4) :474-478.
7Matsunage K, Iwakiri R, Hara M. Endoscopic injection sclerotherapy for esophageal varices in cirrhotic patients with hepatocellular carcinoma: risk factors for survival[J]. J Clin Gastroenterol, 2003,36 (1) : 68-71.
8Yan BM,Lee SS. Emergency management of bleeding esophageal varices : drugs, bands or sleep[J]? Can J Gastroenterol, 2006,20(3):165.
9Avgerinos A,Sgouros S,Viazis N ,et al. Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding :a prospective,randomized,placebo-controlled trial[J]. Scand J Gastroenterol,2005,40(5):515.
10Sever PS,Dahlof B,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomise. The Lancet . 2003
